Prima Nexus / News / Events & workshops

Prima Nexus supported Universiti Malaya's Molecular Medicine Research Day in May 2016

The Department of Molecular Medicine at Universiti Malaya held a day of talks, posters and supporters' booths on 31 May 2016. Prima Nexus supported the day.

· Events & workshops

Six women at the registration desk at Centrepoint, Faculty of Medicine, Universiti Malaya
At the registration desk at Centrepoint, Faculty of Medicine, Universiti Malaya, on the Research Day.

From the Prima Nexus archive: a look back at May 2016.

Prima Nexus supported Molecular Medicine Research Day 2016, held by the Department of Molecular Medicine, Universiti Malaya (UM), at the Faculty of Medicine in Kuala Lumpur on 31 May 2016. From 8.00 am to 4.00 pm, the day brought together five talks, research posters and supporters' booths.

A research day at the Faculty of Medicine

The Research Day ran from 8.00 am to 4.00 pm. Registration, the posters and the supporters' booths were at Centrepoint, and the talks were held in the department's lecture theatre. Academics and students registered in advance with the department. Assoc. Prof. Dr. Sarni Mat Junit, Head of the Department of Molecular Medicine, gave the welcome remarks, and Prof. Dr. Adeeba Kamarulzaman, Dean of the Faculty of Medicine, gave the opening speech.

Five talks, from microRNA to dengue

Five talks filled the morning. Prof. Dr. Fazlul H. Sarkar spoke on microRNA as a molecular bridge between diabetes and cancer, and Prof. Dr. Sekaran Muniandy on dipeptidyl peptidase-4 gene polymorphism. Prof. Dr. Tan Nget Hong covered bioactive proteins from nature, Prof. Dr. Onn Haji Hashim spoke on lectin-based proteomic studies for cancer biomarker discovery, and Prof. Datuk Dr. Rohana Yusof on the design and development of antivirals against dengue.

Between the opening and the talks, participants viewed the posters and visited the supporters' booths over the morning tea break. Lunch was a Science Café in the department's meeting room, supported by the Malaysian Society for Biochemistry and Molecular Biology (MSBMB), and the afternoon went back to the posters and booths, with games and afternoon tea.

A speaker at the lectern presents a slide to a seated audience in a lecture theatre
One of the five morning talks, in the department's lecture theatre.

Prima Nexus's part

Prima Nexus supported the Research Day, and after the event the Department of Molecular Medicine wrote to Prima Nexus to thank the company for its participation and contribution as a supporter. One of the talks dealt with finding cancer biomarkers through proteomics, the large-scale study of proteins. Prima Nexus supports researchers who measure protein biomarkers today through its ELISA and Luminex services, and more photos of the day are on the event page.

About Prima Nexus

Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. Our collaborations have supported more than 150 papers in peer-reviewed journals and research teams at more than 40 institutions across Malaysia. More about Prima Nexus.

Media and partnership enquiries

Prima Nexus Sdn Bhd, Level 2, Mercu Aspire, 59200 KL Eco City, Kuala Lumpur, Malaysia. Email info@primanexus.com.my or WhatsApp 017-305 1076.

Molecular medicineUniversiti MalayaBiomarkersResearch dayCollaboration2016
Share: LinkedIn WhatsApp Facebook X Email

Work with us

Have a study in mind? Tell us what you're trying to discover.

From a single biomarker panel to a multi-site clinical programme, we assemble the platform, assign you one project lead, and stay accountable to your result.